NABI-HB
- Product NDC
- 59730-4203
- 11-digit product format
- 597304203
- Labeler code
- 59730
- Product ID
- 59730-4203_98e263d9-a5c9-393c-e053-2995a90ac2df
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR
- Labeler
- ADMA Biologics, Inc
- Application
- BLA103945
- Marketing category
- BLA
- Marketing start
- 2010-03-12
- Marketing end
- 2022-09-30
- Substance
- HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN
- Active strength
- 1560 [iU]/5mL
- Pharmacologic classes
- Human Immunoglobulin [EPC],Passively Acquired Immunity [PE],Virus Neutralization [MoA],Virus-specific Hyperimmune Globulins [EXT],Immunoglobulins [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 59730-4203-1 | 59730420301 | 5 mL in 1 VIAL (59730-4203-1) | 5 ml | 2010-03-12 | 2022-09-30 | No | No | Current |